Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




PCI Feasible Even in Very Elderly Patients

By HospiMedica International staff writers
Posted on 03 Aug 2016
Percutaneous coronary intervention (PCI) can be safely and successfully performed in patients 90 years of age or older presenting with ST-segment elevation myocardial infarction (STEMI), according to a new study.

Researchers at Pitie-Salpetriere Hospital (Paris, France), Sheba Medical Center (Tel Hashomer, Israel), and other institutions conducted a retrospective study of 145 consecutive all-comer nonagenarians treated with primary PCI for STEMI in five international high-volume centers between 2006 and 2013, in order to assess clinical events and mortality outcomes, which were assessed at six months and one year after the procedure.

The results showed that failed PCI occurred in 11% of patients due to distal embolization, coronary dissection, or inability to pass the wire through the thrombus. More...
Overall, 60% of the procedures were performed through the transradial approach, with successful revascularization of the culprit vessel obtained in 86% of the cases. Major or clinically relevant bleeding was observed in 4% of patients, and in-hospital mortality was 24%. The six-month and one year survival rates were 61% and 53%, respectively. The study was published on July 13, 2016, in Heart.

“Despite intensive antiplatelet and anticoagulant therapy, major or clinically relevant bleeding events were recorded in only six patients during in-hospital follow-up,” concluded lead author Gérard Helft, MD, PhD, of Pitie-Salpetriere Hospital, and colleagues. “The high rate of procedures conducted through the transradial approach may explain the low rate of access site bleeding complications.”

STEMI, a more precise term for heart attack, is caused by a prolonged period of ischemia that affects large areas of the heart. It refers to an identifiable pattern as seen on an electrocardiogram (ECG). Thousands of patients with STEMI fail to receive critical therapy in a timely fashion, and nearly 30% of patients with STEMI do not receive reperfusion treatment at all.

Related Links:
Pitie-Salpetriere Hospital
Sheba Medical Center

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.